NCT03611738 2026-02-09Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLCH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Active not recruiting21 enrolled
NCT04777994 2025-12-23Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsCalico Life Sciences LLCPhase 1 Recruiting248 enrolled